How HNSCC tumors suppress rapid mast cell activation in response to immunoglobulin E or CD32 binding to FcεRI or FCγRIIb respectively remains to be elucidated, but may occur by blocking FcεRI activation on mast cells [121]. This evidence concerns the gene FCGR2B and head and neck squamous cell carcinoma.